We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A

225 hedge funds and large institutions have $2.8B invested in Bio-Rad Laboratories Class A in 2015 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 82 increasing their positions, 82 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

187% more call options, than puts

Call options by funds: $2.68M | Put options by funds: $934K

30% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 23

10% more capital invested

Capital invested by funds: $2.53B → $2.8B (+$264M)

3% more funds holding

Funds holding: 219225 (+6)

0% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 82

0.76% less ownership

Funds ownership: 78.89%78.13% (-0.76%)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
225
Holders Change
+6
Holders Change %
+2.74%
% of All Funds
6.06%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
30
Increased
82
Reduced
82
Closed
23
Calls
$2.68M
Puts
$934K
Net Calls
+$1.75M
Net Calls Change
-$539K
Name Holding Trade Value Shares
Change
Change in
Stake
EGM
226
Engineers Gate Manager
New York
-$1.98M -14,611 Closed
OAC
227
OMERS Administration Corp
Ontario, Canada
-$1.58M -11,700 Closed
PRCM
228
Pine River Capital Management
Minnesota
-$1.48M -10,918 Closed
RA
229
Rational Advisors
New York
-$1.44M -10,650 Closed
MCM
230
Matarin Capital Management
New York
-$1.39M -10,246 Closed
TAM
231
THB Asset Management
Connecticut
-$1.04M -7,665 Closed
Squarepoint
232
Squarepoint
New York
-$591K -4,372 Closed
NV
233
Nair Vinay
-$426K -3,153 Closed
LCM
234
Landscape Capital Management
New Jersey
-$406K -3,000 Closed
Fidelity Investments
235
Fidelity Investments
Massachusetts
-$386K -2,853 Closed
VKH
236
Virtu KCG Holdings
New York
-$335K -2,478 Closed
CT
237
Chicago Trust
Illinois
-$324K -2,395 Closed
GMIM
238
General Motors Investment Management
New York
-$305K -2,257 Closed
Jacobs Levy Equity Management
239
Jacobs Levy Equity Management
New Jersey
-$301K -2,226 Closed
WAM
240
World Asset Management
Michigan
-$219K -1,620 Closed
Creative Planning
241
Creative Planning
Kansas
-$114K -840 Closed
PCM
242
Prelude Capital Management
New York
-$71K -526 Closed
IRS
243
Invictus RG (Singapore)
Singapore
-$14K -100 Closed
TRCT
244
Tower Research Capital (TRC)
New York
-$8K -60 Closed
WCM
245
Wealthcare Capital Management
Virginia
-$7K -50 Closed
IWMPD
246
Integrated Wealth Management (Palm Desert)
California
-$1K -14 Closed
QCG
247
Quadrant Capital Group
Ohio
+$715 +5 New

BIO Hedge Fund Activity: Q2 2015 in Review

225 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q2 2015, worth a combined $2.8B — up 10% from $2.53B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new BIO positions and 23 closed out — a net gain of 7 holders — while 82 added to existing stakes and 82 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $58.8M. The largest seller was American Century Companies, cutting an estimated $48.7M.

  • 225 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q2 2015, up from 219 in Q1 2015.
  • Funds reported $2.8B of Bio-Rad Laboratories Class A stock for Q2 2015, up 10% quarter-over-quarter.
  • 30 funds opened new Bio-Rad Laboratories Class A positions in Q2 2015 and 23 closed out, a net change of +7 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q2 2015 was Acadian Asset Management, an estimated $58.8M added.
  • The largest Bio-Rad Laboratories Class A seller in Q2 2015 was American Century Companies, an estimated $48.7M sold.

Based on aggregated 13F filings for Q2 2015.